Clinical study shows drug has COVID-19 treatment potential
Interim data reportedly indicates Noxopharm’s Veyonda could be effective in treating cytokine storm, an inflammatory effect associated with moderate cases.
Archives for May 11, 2021
Getting cancer trials back on track after COVID-19
A leader from oncology trial insights and analysis specialist Inteliquet discusses how cancer studies can recover after the impact of the global pandemic.
Could synthetic biology solutions fix supply chain challenges?
An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.